The Decibel The ‘miracle drug’ some dog owners regret using
Dec 11, 2024
Susan Krashinsky Robertson, a Globe business reporter, shares her insights on Librela, the controversial arthritis drug for dogs. Some pet owners celebrate its effects, claiming happier, more comfortable pets. However, troubling cases of adverse reactions, including severe lethargy and even death, raise serious concerns. Krashinsky discusses her interviews with pet owners and veterinarians, revealing a critical divide about the drug's safety and the need for better communication in veterinary care. The growing popularity of Librela prompts a closer examination of its risks and regulatory practices.
AI Snips
Chapters
Transcript
Episode notes
Hudson's Experience with Librela
- Ashley Burden's 12-year-old labradoodle, Hudson, was prescribed Librela for arthritis.
- After initial improvement, Hudson's health declined after the third dose, leading to his death.
How Librela Works
- Librela and Silencia are new drugs for arthritis pain in pets.
- They work by disrupting nerve growth factors that send pain signals to the brain.
Initial Perception of Librela
- Ashley Burden wasn't concerned about Librela's side effects.
- Her vet presented it as a low-risk option with minimal side effects, mainly swelling at the injection site.